Form4insider filings, from the source

SEC Form 4 · accession 0001535264-16-000176

Ernexa Therapeutics Inc. · ERNA

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Dec 21, 2016
Accepted (ET)
Dec 28, 2016 · 12:25 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000748592

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Dec 21, 2016S200$9.5001D332,053IBy Limited Partnerships
Common StockF2Dec 22, 2016S2,550$9.1862D329,503IBy Limited Partnerships
Common StockF2Dec 23, 2016S2,602$8.4911D326,901IBy Limited Partnerships
Common StockF1,F2Dec 27, 2016S400$8.5475D326,501IBy Limited Partnerships

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses